In this episode we give an overview of new product approvals by the FDA including Isturisa for Cushing’s disease and added indications for Ofev for chronic fibrosing interstitial lung disease, and the combination of Opdivo and Vervoy for hepatocullular carcinoma. And we’ll be giving our usual update on the novel coronavirus and flu season to date. Don't forget to like, share, and subscribe! Enjoy!